AP4 Share Price Performance
S$0.82
-0.08 (-8.38%)
Price S$0.82
Share PriceS$0.82
Returns On Capital At Riverstone Holdings (SGX:AP4) Paint A Concerning Picture
Oct 12
Riverstone Holdings Limited Stock Price
- 0 Narratives written by author
- 1 Comments on narratives written by author
- 33 Fair Values set on narratives written by author
AP4 Community Narratives
There are no narratives available yet.
Recent AP4 News & Updates
Riverstone Holdings Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.16
- Gross Margin
- 31.79%
- Net Profit Margin
- 22.73%
- Debt/Equity Ratio
- 0%
Riverstone Holdings Limited Competitors
Snowflake Analysis
About AP4
- Founded
- 1989
- Employees
- 3000
- CEO
- WebsiteView website
Riverstone Holdings Limited, an investment holding company, engages in the manufacture and distribution of cleanroom and healthcare gloves in Malaysia, Thailand, and China. The company offers cleanroom gloves, healthcare gloves, cleanroom face masks, fingercots, static shielding bags, face masks, wipers, cleanroom packaging bags, and other cleanroom consumables. It sells its products under the RS brand for use in the hard disk drive and semiconductor industries. It also exports its products to Asia, Europe, and the United States. Riverstone Holdings Limited was founded in 1989 and is based in Singapore.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Singaporean Market Performance
- 7 Days: -2.3%
- 3 Months: 5.8%
- 1 Year: 19.7%
- Year to Date: 16.0%
Over the last 7 days, the market has dropped 2.3%, driven by a decline of 5.3% in the Industrials sector. In contrast to the last week, the market is actually up 20% over the past year. Looking forward, earnings are forecast to grow by 6.6% annually. Market details ›